These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 11241240
1. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection. Yang Y, Forslund A, Remotti H, Lönnroth C, Andersson M, Brevinge H, Svanberg E, Lindnér P, Hafström L, Naredi P, Lundholm K. Cancer; 2001 Feb 15; 91(4):727-36. PubMed ID: 11241240 [Abstract] [Full Text] [Related]
2. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters. Tullo A, D'Erchia AM, Honda K, Mitry RR, Kelly MD, Habib NA, Saccone C, Sbisà E. Clin Cancer Res; 1999 Nov 15; 5(11):3523-8. PubMed ID: 10589767 [Abstract] [Full Text] [Related]
3. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A. Clin Cancer Res; 2005 Jun 01; 11(11):4067-73. PubMed ID: 15930341 [Abstract] [Full Text] [Related]
4. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De Vries EG. Hepatology; 1998 Oct 01; 28(4):971-9. PubMed ID: 9755233 [Abstract] [Full Text] [Related]
5. [p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis]. Yang Y, Xia Q, Lian F. Zhonghua Zhong Liu Za Zhi; 1999 Mar 01; 21(2):114-8. PubMed ID: 11776850 [Abstract] [Full Text] [Related]
6. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Saw RP, Koorey D, Painter D, Gallagher PJ, Solomon MJ. Br J Surg; 2002 Nov 01; 89(11):1409-15. PubMed ID: 12390383 [Abstract] [Full Text] [Related]
13. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients. Khan ZA, Jonas SK, Le-Marer N, Patel H, Wharton RQ, Tarragona A, Ivison A, Allen-Mersh TG. Clin Cancer Res; 2000 Sep 01; 6(9):3499-504. PubMed ID: 10999735 [Abstract] [Full Text] [Related]
14. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Chir Ital; 2005 Sep 01; 57(5):555-70. PubMed ID: 16241086 [Abstract] [Full Text] [Related]
15. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma. Ito T, Kaneko K, Makino R, Konishi K, Kurahashi T, Ito H, Katagiri A, Kushima M, Kusano M, Mitamura K, Imawari M. Oncol Rep; 2003 Sep 01; 10(6):1937-42. PubMed ID: 14534722 [Abstract] [Full Text] [Related]
16. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J, Jassem E, Jakóbkiewicz-Banecka J, Rzyman W, Badzio A, Dziadziuszko R, Kobierska-Gulida G, Szymanowska A, Skrzypski M, Zylicz M. Cancer; 2004 May 01; 100(9):1951-60. PubMed ID: 15112277 [Abstract] [Full Text] [Related]